Published In
B-ENT
Volume 8 · Issue 4
Pages: 285-288
History
Published Online: December 15, 2012
D. Malinvaud
Department of ENT and Auditory Research Laboratory, Formation Associée Claude Bernard and CNRS UMR 8194, Hôpital Européen Georges Pompidou, Faculté de médecine Paris V, Université René Descartes, Paris, France
C. Badoual
Department of Pathology, Hôpital Européen Georges Pompidou, Paris cedex 15, Faculté de médecine Paris V, Université René Descartes, France
M.T. Rubio
Department of Hematology, Hôpital Necker, Faculté de médecine Paris V, Université René Descartes, Paris, France
Ph. Halimi
Department of Radiology, Hôpital Européen Georges Pompidou, Faculté de médecine Paris V, Université René Descartes, Paris, France
P. Bonfils
Department of ENT and Auditory Research Laboratory, Formation Associée Claude Bernard and CNRS UMR 8194, Hôpital Européen Georges Pompidou, Faculté de médecine Paris V, Université René Descartes, Paris, France
Malinvaud, D., Badoual, C., Rubio, M., Halimi, P., & Bonfils, P. (2012). Extraosseous plasmacytoma of the lacrimal duct. B-ENT, 8(4), 285–288. Retrieved from https://www.b-ent.be/index.php/pub/article/view/451
Full Text
Full Text PDF
Full Text PDF
Abstract
Extraosseous plasmacytoma of the lacrimal duct. Objective: Extraosseous plasmacytoma (EOP) is a rare plasma cell proliferative disorder that commonly affects the head and neck region. We report the first case of a plasmacytoma of the lacrimal duct.
Methods: A 66-year-old man presented with an isolated plasmacytoma of the right lacrimal duct and was treated surgically.
Results: The tumour grew slowly for a few months. CT scan and MRI showed a right lateral nasal mass extending from the right lacrimal duct toward the floor of the right maxillary sinus. The lesion was removed completely by endoscopic nasal surgery.
Discussion: EOP accounts for up to 3% of all plasma cell tumours. Management of this rare lesion involves surgery and radiotherapy with or without adjuvant chemotherapy. Guided by a literature review, we discuss the diagnostic and therapeutic management of EOP.
Similar Articles
Article Info
Published In
Journal
B-ENT
Volume / Issue
Volume 8 · Issue 4
Pages
285-288
History
Published Online
December 15, 2012
Affiliations
D. Malinvaud
Department of ENT and Auditory Research Laboratory, Formation Associée Claude Bernard and CNRS UMR 8194, Hôpital Européen Georges Pompidou, Faculté de médecine Paris V, Université René Descartes, Paris, France
C. Badoual
Department of Pathology, Hôpital Européen Georges Pompidou, Paris cedex 15, Faculté de médecine Paris V, Université René Descartes, France
M.T. Rubio
Department of Hematology, Hôpital Necker, Faculté de médecine Paris V, Université René Descartes, Paris, France
Ph. Halimi
Department of Radiology, Hôpital Européen Georges Pompidou, Faculté de médecine Paris V, Université René Descartes, Paris, France
P. Bonfils
Department of ENT and Auditory Research Laboratory, Formation Associée Claude Bernard and CNRS UMR 8194, Hôpital Européen Georges Pompidou, Faculté de médecine Paris V, Université René Descartes, Paris, France
Cite this Article
Malinvaud, D., Badoual, C., Rubio, M., Halimi, P., & Bonfils, P. (2012). Extraosseous plasmacytoma of the lacrimal duct. B-ENT, 8(4), 285–288. Retrieved from https://www.b-ent.be/index.php/pub/article/view/451
Outlines